anti-GPCR antibodies (Sosei Heptares/MorphoSys)

N/A

Report date: 2025/03/14 16:22:39

Base Information

Drug Nameanti-GPCR antibodies (Sosei Heptares/MorphoSys)
Drug Alias Nameanti-GPCR antibodies (Heptares/MorphoSys)anti-PAR2 therapeutics (Sosei Heptares/MorphoSys)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionProtease-activated receptor-2 antagonists
TargetsProtease-activated receptor-2
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNxera Pharma UK Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNxera Pharma Co Ltd
Inactive CompaniesMorphosys AgNxera Pharma UK Ltd
Active IndicationsDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A